Tandem Diabetes Care, Inc. Payments to Acquire Short-term Investments
Tandem Diabetes Care, Inc. (TNDM) reported Payments to Acquire Short-term Investments of $260.51 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2026-08-06
- Tandem Diabetes Care, Inc. payments to acquire short-term investments for the quarter ending 2026-06-30 was $44.38M, a 160.37% increase year-over-year.
- Tandem Diabetes Care, Inc. payments to acquire short-term investments for the quarter ending 2026-03-31 was $216.13M, a 2187.09% increase year-over-year.
- Tandem Diabetes Care, Inc. payments to acquire short-term investments for the quarter ending 2025-12-31 was $29.66M, a 129.00% increase year-over-year.
- Tandem Diabetes Care, Inc. payments to acquire short-term investments for the quarter ending 2025-09-30 was $29.51M, a 59.93% decline year-over-year.
- Tandem Diabetes Care, Inc. payments to acquire short-term investments for fiscal 2025 was $85.66M, a 67.59% decline from fiscal 2024.
- Tandem Diabetes Care, Inc. payments to acquire short-term investments for fiscal 2024 was $264.31M, a 48.26% decline from fiscal 2023.
- Tandem Diabetes Care, Inc. payments to acquire short-term investments for fiscal 2023 was $510.86M, a 9.24% increase from fiscal 2022.
- Tandem Diabetes Care, Inc. payments to acquire short-term investments for fiscal 2022 was $467.65M, a 36.23% decline from fiscal 2021.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 3 month as first filed | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 6 month as first filed | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 9 month as first filed | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $44.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $260.51M 10-Q · filed 2026-08-06 | $290.17M derived: sum of 3 quarters · filed 2026-08-06 | $319.68M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $216.13M 10-Q · filed 2026-05-07 | $245.79M derived: sum of 2 quarters · filed 2026-05-07 | $275.29M derived: sum of 3 quarters · filed 2026-05-07 | $292.34M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $29.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $59.16M derived: sum of 2 quarters · filed 2026-02-19 | $76.21M derived: sum of 3 quarters · filed 2026-08-06 | $85.66M 10-K · filed 2026-02-19 | |||
| 2025-09-30 | $29.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $46.55M derived: sum of 2 quarters · filed 2026-08-06 | $56.00M 10-Q · filed 2025-11-06 | $68.95M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $17.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $26.50M 10-Q · filed 2026-08-06 | $39.45M derived: sum of 3 quarters · filed 2026-08-06 | $113.08M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $9.45M 10-Q · filed 2026-05-07 | $22.40M derived: sum of 2 quarters · filed 2026-05-07 | $96.04M derived: sum of 3 quarters · filed 2026-05-07 | $189.51M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $12.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $86.59M derived: sum of 2 quarters · filed 2026-02-19 | $180.06M derived: sum of 3 quarters · filed 2026-02-19 | $264.31M 10-K · filed 2026-02-19 | |||
| 2024-09-30 | $73.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $167.11M derived: sum of 2 quarters · filed 2025-11-06 | $251.36M 10-Q · filed 2025-11-06 | $371.19M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-06-30 | $93.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $177.72M 10-Q · filed 2025-08-06 | $297.56M derived: sum of 3 quarters · filed 2026-02-19 | $453.06M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-03-31 | $84.25M 10-Q · filed 2025-04-30 | $204.08M derived: sum of 2 quarters · filed 2026-02-19 | $359.58M derived: sum of 3 quarters · filed 2026-02-19 | $485.99M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2023-12-31 | $119.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $275.33M derived: sum of 2 quarters · filed 2026-02-19 | $401.74M derived: sum of 3 quarters · filed 2026-02-19 | $510.86M 10-K · filed 2026-02-19 | |||
| 2023-09-30 | $155.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $281.91M derived: sum of 2 quarters · filed 2024-11-06 | $391.02M 10-Q · filed 2024-11-06 | $496.18M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-06-30 | $126.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $235.53M 10-Q · filed 2024-08-01 | $340.68M derived: sum of 3 quarters · filed 2025-02-26 | $473.46M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-03-31 | $109.11M 10-Q · filed 2024-05-02 | $214.27M derived: sum of 2 quarters · filed 2025-02-26 | $347.05M derived: sum of 3 quarters · filed 2025-02-26 | $466.05M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2022-12-31 | $105.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $237.93M derived: sum of 2 quarters · filed 2025-02-26 | $356.93M derived: sum of 3 quarters · filed 2025-02-26 | $467.65M 10-K · filed 2025-02-26 | |||
| 2022-09-30 | $132.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $251.78M derived: sum of 2 quarters · filed 2023-11-01 | $362.49M 10-Q · filed 2023-11-01 | $553.04M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-06-30 | $119.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $229.72M 10-Q · filed 2023-08-03 | $420.27M derived: sum of 3 quarters · filed 2024-02-21 | $577.53M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-03-31 | $110.72M 10-Q · filed 2023-05-03 | $301.27M derived: sum of 2 quarters · filed 2024-02-21 | $458.53M derived: sum of 3 quarters · filed 2024-02-21 | $689.81M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2021-12-31 | $190.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $347.81M derived: sum of 2 quarters · filed 2024-02-21 | $579.09M derived: sum of 3 quarters · filed 2024-02-21 | $733.39M 10-K · filed 2024-02-21 | |||
| 2021-09-30 | $157.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $388.54M derived: sum of 2 quarters · filed 2022-11-02 | $542.84M 10-Q · filed 2022-11-02 | $707.95M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-06-30 | $231.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $385.58M 10-Q · filed 2022-08-03 | $550.69M derived: sum of 3 quarters · filed 2023-02-22 | $715.67M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-03-31 | $154.30M 10-Q · filed 2022-05-04 | $319.41M derived: sum of 2 quarters · filed 2023-02-22 | $484.39M derived: sum of 3 quarters · filed 2023-02-22 | $641.65M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2020-12-31 | $165.11M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $330.09M derived: sum of 2 quarters · filed 2023-02-22 | $487.35M derived: sum of 3 quarters · filed 2023-02-22 | $497.08M 10-K · filed 2023-02-22 | |||
| 2020-09-30 | $164.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $322.24M derived: sum of 2 quarters · filed 2021-11-03 | $331.97M 10-Q · filed 2021-11-03 | $370.23M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-06-30 | $157.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $166.98M 10-Q · filed 2021-08-04 | $205.25M derived: sum of 3 quarters · filed 2022-02-22 | $257.39M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-03-31 | $9.73M 10-Q · filed 2021-05-05 | $47.99M derived: sum of 2 quarters · filed 2022-02-22 | $100.14M derived: sum of 3 quarters · filed 2022-02-22 | $131.38M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2019-12-31 | $38.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $90.41M derived: sum of 2 quarters · filed 2022-02-22 | $121.66M derived: sum of 3 quarters · filed 2022-02-22 | $164.57M 10-K · filed 2022-02-22 | |||
| 2019-09-30 | $52.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $83.39M derived: sum of 2 quarters · filed 2020-11-05 | $126.31M 10-Q · filed 2020-11-05 | $149.31M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-06-30 | $31.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $74.16M 10-Q · filed 2020-07-30 | $97.17M derived: sum of 3 quarters · filed 2021-02-24 | $157.22M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-03-31 | $42.91M 10-Q · filed 2020-04-30 | $65.92M derived: sum of 2 quarters · filed 2021-02-24 | $125.97M derived: sum of 3 quarters · filed 2021-02-24 | $157.47M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2018-12-31 | $23.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $83.05M derived: sum of 2 quarters · filed 2021-02-24 | $114.55M derived: sum of 3 quarters · filed 2021-02-24 | $123.55M 10-K · filed 2021-02-24 | |||
| 2018-09-30 | $60.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $91.55M derived: sum of 2 quarters · filed 2019-11-04 | $100.55M 10-Q · filed 2019-11-04 | ||||
| 2018-06-30 | $31.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $40.50M 10-Q · filed 2019-08-01 | |||||
| 2018-03-31 | $9.00M 10-Q · filed 2019-04-30 | ||||||
| 2017-12-31 | $0.00 10-K · filed 2020-02-24 | ||||||
| 2016-12-31 | $4.73M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $7.96M derived: sum of 2 quarters · filed 2019-02-26 | $17.18M derived: sum of 3 quarters · filed 2019-02-26 | $30.62M 10-K · filed 2019-02-26 | |||
| 2016-09-30 | $3.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $12.45M derived: sum of 2 quarters · filed 2017-10-26 | $25.89M 10-Q · filed 2017-10-26 | $38.61M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | $9.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $22.66M 10-Q · filed 2017-07-27 | $35.38M derived: sum of 3 quarters · filed 2018-03-01 | $43.85M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-03-31 | $13.44M 10-Q · filed 2017-04-27 | $26.16M derived: sum of 2 quarters · filed 2018-03-01 | $34.64M derived: sum of 3 quarters · filed 2018-03-01 | $54.53M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $12.72M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $21.20M derived: sum of 2 quarters · filed 2018-03-01 | $41.09M derived: sum of 3 quarters · filed 2018-03-01 | $80.19M 10-K · filed 2018-03-01 | |||
| 2015-09-30 | $8.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $28.37M derived: sum of 2 quarters · filed 2016-11-01 | $67.47M 10-Q · filed 2016-11-01 | $72.72M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2015-06-30 | $19.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $58.99M 10-Q · filed 2016-07-28 | $64.24M derived: sum of 3 quarters · filed 2017-03-08 | $90.27M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2015-03-31 | $39.10M 10-Q · filed 2016-04-28 | $44.34M derived: sum of 2 quarters · filed 2017-03-08 | $70.37M derived: sum of 3 quarters · filed 2017-03-08 | $77.37M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2014-12-31 | $5.25M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $31.27M derived: sum of 2 quarters · filed 2017-03-08 | $38.27M derived: sum of 3 quarters · filed 2017-03-08 | $67.10M 10-K · filed 2017-03-08 | |||
| 2014-09-30 | $26.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $33.02M derived: sum of 2 quarters · filed 2015-10-29 | $61.86M 10-Q · filed 2015-10-29 | $61.86M 10-Q · filed 2014-11-06 | |||
| 2014-06-30 | $7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $35.83M 10-Q · filed 2015-07-30 | $35.83M 10-Q · filed 2014-07-31 | ||||
| 2014-03-31 | $28.83M 10-Q · filed 2015-04-30 | $28.83M 10-Q · filed 2014-05-06 | |||||
| 2013-12-31 | $5.09M 10-K · filed 2016-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |